Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06624696
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-30
Brief Title:
A Randomized Controlled Study of Inhaling Penehyclidine for Preventing Perioperative Respiratory Adverse Events in Children at Risk
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Inhaling Penehyclidine to Prevent Perioperative Respiratory Adverse Events in Children at Risk Undergoing Minor Elective Surgery
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PEPSI
Brief Summary:
This randomized controlled study is to evaluate the effectiveness of inhaling penehyclidine hydrochloride in reducing perioperative respiratory adverse events in children at risk undergoing minor elective surgery
Detailed Description:
Children with high risk factors of perioperative respiratory adverse events PRAEs remains a challenge for general anesthesia inhalation of penehyclidine hydrochloride PHC has been showed to reduce postoperative pulmonary complications and enhance the recovery in high-risk surgical patients Thus prophylactic PHC inhalation might show promising benefits against PRAEs in pediatric anesthesia This clinical study is designed to test the hypothesis that pediatric patients who exist at least 1 risk factor of PRAEs prophylactically to inhale PHC have a lower prevalence of PRAEs
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None